Sepsis
Sepsis
Explore linked clinical trials. Standard reference: MESH:M0028155602 results · Page 1 of 25
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pre-induction Norepinephrine in Septic Patients Undergoing Surgery | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, cardiovascular disorder, hypotensive disorder, vascular disorder | Not yet recruiting | Not applicable | 2026-10-09 | NCT07869693 | |
| THiamine for Recovery In Vulnerable Early-life Infections | Bacterial Infections and Mycoses, Infections, Inflammation, Neuroinflammatory Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, bacterial infectious disease, bacterial infectious disease with sepsis, meningitis, nervous system disorder | Not yet recruiting | Phase 2 | 2026-10-09 | NCT07868679 | |
| Immune Dysregulation During Sepsis: A Natural History Cohort | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Not yet recruiting | Not stated | 2026-10-09 | NCT07735741 | |
| Remote Ischemic Postconditioning in Septic Shock | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Not yet recruiting | Not applicable | 2026-10-09 | NCT07273942 | |
| Impact of Blood Cultures Drawn From Arterial Lines on the Incidence of Contamination, Detection of Bacteremia, and Blood Culture Volume | Bacterial Infections and Mycoses, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, bacterial infectious disease, bacterial infectious disease with sepsis | Recruiting | Not stated | 2026-10-09 | NCT07183410 | |
| Sepsis Biomarker Monitoring in Burn Patients | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, burn, injury | Not yet recruiting | Not applicable | 2026-10-08 | NCT07866521 | |
| Thymalfasin for Immune Recovery in Adults With Sepsis | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome | Recruiting | Not applicable | 2026-10-08 | NCT07866118 | |
| HOPE-Sepsis: Hemoadsorption Therapy for Sepsis | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Not yet recruiting | Not applicable | 2026-10-08 | NCT07865585 | |
| Sepsis ICU Gut Microbiome Analysis | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Not yet recruiting | Not stated | 2026-10-08 | NCT07864818 | |
| Evaluation of Diagnostic Accuracy and Clinical Performance of the UllCORE Bloodstream Infection (BSI) Test | Bacterial Infections and Mycoses, Fungemia, Infections, Inflammation, Invasive Fungal Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, bacterial infectious disease, bacterial infectious disease with sepsis, fungal infectious disease | Recruiting | Not stated | 2026-10-08 | NCT07859852 | |
| THE ROLE OF PANCREATIC STONE PROTEIN (PSP) AND PSP-GUIDED EARLY MEROPENEM TREATMENT TO MITIGATE SEPSIS RISK AT THE EMERGENCY DEPARTMENT: THE PROMISE DOUBLE BLIND, PHASE III, RANDOMIZED CONTROLLED CLINICAL TRIAL | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome | Recruiting | Phase 3 | 2026-10-08 | NCT07813767 | |
| Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast With Patient Blood Samples | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Not yet recruiting | Not stated | 2026-10-08 | NCT06531031 | |
| Direct In-Scope Suction Versus Standard Flexible Ureterorenoscopy | Calculi, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Inflammation, Kidney Calculi, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, Urinary Calculi, Urogenital Diseases, kidney disorder, nephrolithiasis, urinary system disorder, urinary tract infection, urolithiasis | Recruiting | Not applicable | 2026-10-07 | NCT07864194 | |
| Multicenter Prospective Cohort of Sepsis and ARDS in China | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome | Recruiting | Not stated | 2026-10-07 | NCT07863908 | |
| Non-invasive Hemodynamic Optimization of Sepsis in Internal Medicine: a Randomized Study Comparing Therapy Guided by Non-invasive Hemodynamic Indices Versus Standard of Care. | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Recruiting | Not applicable | 2026-10-07 | NCT07863323 | |
| Long-Term Recovery and Quality of Life in Sepsis Survivors | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome | Recruiting | Not stated | 2026-10-07 | NCT07863128 | |
| Effect of Adjunctive Ursodeoxycholic Acid on Oxidative Stress, Inflammation, and Organ Dysfunction in Adults With Sepsis | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome | Not yet recruiting | Phase 2 / Phase 3 | 2026-10-07 | NCT07852780 | |
| Microbiome and Enteric Signatures in Sepsis-associated Hepatorenal Injury | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome | Recruiting | Not stated | 2026-10-07 | NCT07735182 | |
| Plasma Exchange in Children With Severe Sepsis and Septic Shock | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Severe Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Recruiting | Not applicable | 2026-10-07 | NCT07706413 | |
| IMMUNOREA - Immunological and Inflammatory Determinants Associated With the Prognosis of Intensive Care Patients | Critical Illness, Disease Attributes, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, iatrogenic disease, nosocomial infection | Recruiting | Not stated | 2026-10-07 | NCT07345169 | |
| Point of Care - Sepsis Study | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, porphyria cutanea tarda | Recruiting | Not stated | 2026-10-06 | NCT07774013 | |
| Effect of Targeting Upper Normal Serum Magnesium Levels on Norepinephrine Requirements in Septic Shock Patients | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Recruiting | Not applicable | 2026-10-06 | NCT07716956 | |
| Dynamic SvO2 in Predicting Fluid Responsiveness in Septic Shock | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Recruiting | Not stated | 2026-10-06 | NCT07516236 | |
| A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa) | Bacterial Infections and Mycoses, Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Inflammation, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, Urogenital Diseases, bacterial infectious disease, chronic renal failure syndrome, gram-positive bacterial infections, kidney disorder, kidney failure, staphylococcal infection, urinary system disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-06 | NCT06749457 | |
| Protocolized Reduction of Non-resuscitation Fluids Versus Usual Care in Septic Shock Patients | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Recruiting | Not applicable | 2026-10-06 | NCT06140147 |